{"id":59779,"date":"2015-09-07T20:21:58","date_gmt":"2015-09-08T00:21:58","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=59779"},"modified":"2015-09-07T20:27:47","modified_gmt":"2015-09-08T00:27:47","slug":"anything-goes","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2015\/09\/07\/anything-goes\/","title":{"rendered":"anything goes…"},"content":{"rendered":"
"There is only one difference between a bad economist and a good one: the bad economist confines himself to the visible<\/em> effect; the good economist takes into account both the effect that can be seen and those effects that must be foreseen…"<\/font><\/em><\/sup><\/div>\n
                French Journalist\/Economist Fr\u00e9d\u00e9ric Bastiat<\/a><\/font><\/em><\/sup><\/div>\n

The Law of Unintended Consequences is an all too frequent force in the best laid plans of mice and men – derailing the most well meant reforms. It’s like an unseen ghost, lurking behind every tree just waiting to pop out when you least expect it. At the risk of a mundane example, the Kudzu on the sides of some of our Southern byways was actively imported by TVA in its early days to control erosion, but lingers in perpetuity choking everything in its path.<\/p>\n

Back in 2001 when Paxil Study 329<\/a> was first published, it was a genuine shock to discover that it was ghost-written by professional medical writer, Sally Laden, who created the first draft of that article and oversaw the the subsequent revisions [and other paperwork]:<\/div>\n
\n
Children’s Hospital of Philadelphia [Dr. Weller]; North America Medical Affairs, GlaxoSmithKIine, Collegeville, PA [Ms. Oakes, Mr. McCafferty]. This study was supported by a grant from GlaxoSmithKline, Collegeville. PA. Children’s Hospital of Philadelphia [Dr. Weller]; North America Medical Affairs, ClaxoSmithKIine, Collegeville, PA [Ms. Oakes, Mr. McCafferty]. This study was supported by a grant from GlaxoSmithKline, Collegeville. PA. The authors acknowledge the contributions of the following individuals; Jill M. Abbott, Ellen Basian Ph.D.. Carolyn Boulos, M.D., Elyse Dubo, M.D., Mary A. Fristad. Ph.D., Joan Hebeler. M.D.. Kevin Kelly. Ph.D.. Sharon Reiter. M.D.. and Ronald A. Weller. M.D. Editorial assistance was provided by Sally K. Laden. MS<\/font><\/strong>.<\/div>\n<\/blockquote>\n
By then, the funding source and the authors who were company employees were also being regularly acknowledged, though the COIs of the authors weren’t mentioned; ClinicalTrials.gov for trial registration was in its infancy; and Propublica\/Sunshine Act declarations were just a dream in the minds of a few:<\/div>\n